CN Patent

CN115715765A — 一种悬浮片剂

Assigned to Shanghai Fosun Xingtai Pharma Technology Co ltd · Expires 2023-02-28 · 3y expired

What this patent protects

本发明涉及一种悬浮片剂，包括以下重量百分比的成分：药物2％‑30％、水溶性溶胀聚合物10‑70％、辛酸葵酸聚乙二醇甘油酯0.1％‑5％、产气剂8‑50％、赋形剂10‑50％、助流剂0.1％‑5％、润滑剂0.1％‑5％，促渗剂0‑7％，各组分相加为100％。其片剂在浸入酸溶液之后，片剂表面崩解，片芯继续漂浮。因此，片剂快速漂浮同时释放部分药物，然后，片剂继续漂浮，缓释药物。同时，辛酸葵酸聚乙二醇甘油酯可以增加片剂的吸水性，促进凝胶骨架的形成。

USPTO Abstract

本发明涉及一种悬浮片剂，包括以下重量百分比的成分：药物2％‑30％、水溶性溶胀聚合物10‑70％、辛酸葵酸聚乙二醇甘油酯0.1％‑5％、产气剂8‑50％、赋形剂10‑50％、助流剂0.1％‑5％、润滑剂0.1％‑5％，促渗剂0‑7％，各组分相加为100％。其片剂在浸入酸溶液之后，片剂表面崩解，片芯继续漂浮。因此，片剂快速漂浮同时释放部分药物，然后，片剂继续漂浮，缓释药物。同时，辛酸葵酸聚乙二醇甘油酯可以增加片剂的吸水性，促进凝胶骨架的形成。

Drugs covered by this patent

pyridostigmine-bromide (PYRIDOSTIGMINE BROMIDE)

Patent Metadata

Patent number: CN115715765A
Jurisdiction: CN
Classification: —
Expires: 2023-02-28
Drug substance claim: No
Drug product claim: No
Assignee: Shanghai Fosun Xingtai Pharma Technology Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.